Officials accused UMR, a UnitedHealth TPA, of basing ER claim decisions on diagnosis codes rather than symptoms.
Cantor Fitzgerald reaffirmed its Neutral stance on Humana (NYSE:HUM) stock, maintaining the price target at $290.00. The stock, currently trading at $257.34, has experienced a significant 11.4% ...